SHANGHAI, March 14, 2024 /PRNewswire/ — D3 Bio, an emerging global biotechnology company that focuses on discovery, development, and registration of innovative cancer drugs, welcomes Antoine Yver, MD. ,MSc. as the new independent board member, effective March 4, 2024. Dr. Yver has 34…